Literature DB >> 9808670

Inhibition of delayed rectifier K+ channels by dexfenfluramine (Redux).

S Hu1, S Wang, J Gibson, T A Gilbertson.   

Abstract

In light of recent reports linking K+ channel modulation with food intake and macronutrient preference, we investigated the effect of anorectic agent dexfenfluramine (d-FF), a 5-HT reuptake inhibitor and releasing agent, on the delayed rectifier K+ (DRK) channels in rat lingual taste cells using the patch-clamp technique in whole-cell configuration. In a concentration-dependent manner, d-FF caused a reduction of the DRK currents in taste cells with an IC50 of 30.5 microM. Other anorectics that promote 5-HT activity such as fenfluramine, sibutramine and m-chlorophenylpiperazine (a specific 5-HT2C receptor agonist) produced inhibition of DRK currents of a similar pattern with a respective IC50 of 69.0, 8.6 and 95.4 microM. The actions of all compounds had rapid onset and were readily reversible. The inhibitory effects were not secondary to their stimulation of 5-HT, because direct application of 5-HT up to 1 mM did not alter DRK current. In addition, d-FF-induced current reduction was not prevented by either the 5-HT synthesis inhibitor p-chlorophenylalanine or 5-HT receptor antagonist metergoline. d-FF was also tested in cardiac ventricular myocytes that are reportedly abundant in DRK channels and was found to depress the DRK currents concentration-dependently with an IC50 of 250.9 microM. These results indicate an important pharmacological role for d-FF as an inhibitor of the DRK channels. The common inhibitory effect on DRK channels in oral taste cells and cardiac cells by this class of compounds might contribute to the anorectic and some of the detrimental cardiovascular effect associated with long-term exposure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808670

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Detection of duodenal ulcer-associated genes in rats.

Authors:  Xiaoming Deng; Sandor Szabo; Tetyana Khomenko; Martin R Jadus; Masashi Yoshida; Longchuan Chen
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

2.  4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels.

Authors:  Renato Pirisino; Nicoletta Galeotti; Silvia Livi; Laura Raimondi; Carla Ghelardini
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Linking pharmacovigilance with pharmacogenetics.

Authors:  David W J Clark; Emma Donnelly; David M Coulter; Rebecca L Roberts; Martin A Kennedy
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.

Authors:  R Pirisino; C Ghelardini; G Banchelli; N Galeotti; L Raimondi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  QT interval prolongation associated with sibutramine treatment.

Authors:  Mira Harrison-Woolrych; David W J Clark; Geraldine R Hill; Mark I Rees; Jonathan R Skinner
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

6.  Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism.

Authors:  Steven M Graves; Mary J Clark; John R Traynor; Xiu-Ti Hu; T Celeste Napier
Journal:  Neuropharmacology       Date:  2014-09-16       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.